Becker's Healthcare September 16, 2024
Sanofi received FDA approval for a new manufacturing line to expand production of Beyfortus, a preventive therapy for respiratory syncytial virus in infants.
Beyfortus is the first long-acting monoclonal antibody approved by the FDA to prevent RSV-related lower respiratory tract disease in...